Pozzilli P, Di Mario U, Javicoli M, Menzinger G, Andreani D
Acta Endocrinol (Copenh). 1980 Jan;93(1):49-53. doi: 10.1530/acta.0.0930049.
Sera from 64 juvenile onset insulin-dependent diabetics (Type I diabetics) and 30 normal subjects were tested for their ability to inhibit sheep red blood cell rosette formation (E-rosette) by normal allogeneic lymphocytes. Inhibition of E-rosette formation by greater than 20% was found with 16 (66%) sera from newly diagnosed patients, 3 (16%) sera from patients with duration of disease between 2 and 12 months and with 4 (18%) sera from diabetics with duration of disease between 1 and 7 years. On the other hand, only 2 (6%) control sera showed inhibitory effect. No relationship between E-rosette inhibition and islet-cell antibodies presence, anti-lymphocyte antibodies occurrence, anti-HLA activity, blood glucose levels, respectively, was found. Investigation of the properties of this inhibitory factor suggests that it is different from other substances that reportedly inhibit E-rosette formation.
检测了64例青少年起病的胰岛素依赖型糖尿病患者(Ⅰ型糖尿病患者)和30名正常受试者的血清抑制正常同种异体淋巴细胞形成绵羊红细胞玫瑰花结(E-玫瑰花结)的能力。发现新诊断患者的16份血清(66%)、病程在2至12个月之间患者的3份血清(16%)以及病程在1至7年之间的糖尿病患者的4份血清(18%)对E-玫瑰花结形成的抑制率大于20%。另一方面,只有2份对照血清(6%)显示出抑制作用。未发现E-玫瑰花结抑制与胰岛细胞抗体的存在、抗淋巴细胞抗体的出现、抗HLA活性、血糖水平之间存在相关性。对这种抑制因子特性的研究表明,它与据报道抑制E-玫瑰花结形成的其他物质不同。